Luveris 75IU Injection
By Luveris
Rx
1 Injection in a Vial

Composition
Recombinant Human Luteinizing hormone(75IU)

Manufacturer - Merck Ltd
L-2, J.R. Complex, Gate No. 4, Village Mandoli, Delhi-110 093, India

Expires on or after
October, 2025

liver
Individuals with severe liver disease should exercise caution when using Luveris 75IU Injection. It may be necessary to adjust the dose of Luveris 75IU Injection in such cases. It is important for patients with liver issues to consult their healthcare provider before using this medication to ensure proper management and safety.

kidney
Luveris 75IU Injection may require dose adjustment and caution in patients with kidney disease. Consult your doctor for proper guidance.

alcohol
Consult your doctor when consuming alcohol with Luveris 75IU Injection.

driving
It is not confirmed if Luveris 75IU Injection impacts driving. Do not drive if you have symptoms affecting focus and reaction time.

pregnancy
Luveris 75IU Injection is not safe to use during pregnancy. Studies on pregnant women and animals have shown harmful effects on the developing baby. It is important to seek your doctor's advice before considering this medication during pregnancy.

breastfeeding
It is better to consult your doctor before using Luveris 75IU Injection during breastfeeding.
Habit Forming | No |
Chemical Class | Peptides |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | Gonadotropins |
₹2137
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025